These recent transactions mark the latest of several strategic initiatives undertaken by ImproMed. The Baker Tilly team has been instrumental in our acquisitions by identifying potential sellers/partners, developing creative structures, and negotiating successful transactions that mirror our strategic vision.Ron Detjen, President and CEO, ImproMed, Inc.